Clinical Experience and Workflow Challenges with Magnetic Resonance-only Radiation Therapy Simulation and Planning for Prostate Cancer

Overview

Journal Phys Imaging Radiat Oncol

Specialty Oncology

Date 2020 Nov 2

PMID 33134566

Citations 18

Authors

Neelam Tyagi

Michael J Zelefsky

Andreas Wibmer

Kristen Zakian

Sarah Burleson

Laura Happersett

Aleksi Halkola

Mo Kadbi

Margie Hunt

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: Magnetic Resonance (MR)-only planning has been implemented clinically for radiotherapy of prostate cancer. However, fewer studies exist regarding the overall success rate of MR-only workflows. We report on successes and challenges of implementing MR-only workflows for prostate.

Materials And Methods: A total of 585 patients with prostate cancer underwent an MR-only simulation and planning between 06/2016-06/2018. MR simulation included images for contouring, synthetic-CT generation and fiducial identification. Workflow interruptions occurred that required a backup CT, a re-simulation or an update to our current quality assurance (QA) process. The challenges were prospectively evaluated and classified into syn-CT generation, motion/artifacts in the MRs, fiducial QA and bowel preparation guidelines.

Results: MR-only simulation was successful in 544 (93.2 %) patients. . In seventeen patients (2.9%), reconstruction of synthetic-CT failed due to patient size, femur angulation, or failure to determine the body contour. Twenty-four patients (4.1%) underwent a repeat/backup CT scan because of artifacts on the MR such as image blur due to patient motion or biopsy/surgical artifacts that hampered identification of the implanted fiducial markers. In patients requiring large coverage due to nodal involvement, inhomogeneity artifacts were resolved by using a two-stack acquisition and adaptive inhomogeneity correction. Bowel preparation guidelines were modified to address frequent rectum/gas issues due to longer MR scan time.

Conclusions: MR-only simulation has been successfully implemented for a majority of patients in the clinic. However, MR-CT or CT-only pathway may still be needed for patients where MR-only solution fails or patients with MR contraindications.

Citing Articles

Feasibility of quantitative relaxometry for prostate target localization and response assessment in magnetic resonance-guided online adaptive stereotactic body radiotherapy.

Subashi E, LoCastro E, Burleson S, Apte A, Zelefsky M, Tyagi N Phys Imaging Radiat Oncol. 2024; 32():100678.

PMID: 39717186 PMC: 11665667. DOI: 10.1016/j.phro.2024.100678.

Advancing the Collaboration Between Imaging and Radiation Oncology.

Jia X, Carter B, Duffton A, Harris E, Hobbs R, Li H Semin Radiat Oncol. 2024; 34(4):402-417.

PMID: 39271275 PMC: 11407744. DOI: 10.1016/j.semradonc.2024.07.005.

Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon.

Tseng C, Zeng K, Mellon E, Soltys S, Ruschin M, Lau A Neuro Oncol. 2024; 26(12 Suppl 2):S3-S16.

PMID: 38437669 PMC: 10911794. DOI: 10.1093/neuonc/noad258.

Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review.

Dornisch A, Zhong A, Poon D, Tree A, Seibert T World J Urol. 2024; 42(1):56.

PMID: 38244059 PMC: 10799816. DOI: 10.1007/s00345-023-04745-w.

Potential dosimetric error in the adaptive workflow of a 1.5 T MR-Linac from patient movement relative to immobilisation systems.

Liu M, Tang B, Orlandini L, Li J, Wang X, Peng Q Phys Eng Sci Med. 2024; 47(1):351-359.

PMID: 38227140 PMC: 10963571. DOI: 10.1007/s13246-023-01369-7.

References

Kim J, Miller B, Siddiqui M, Movsas B, Glide-Hurst C . FMEA of MR-Only Treatment Planning in the Pelvis. Adv Radiat Oncol. 2019; 4(1):168-176. PMC: 6349599. DOI: 10.1016/j.adro.2018.08.024. View

Persson E, Gustafsson C, Ambolt P, Engelholm S, Ceberg S, Back S . MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria. Radiat Oncol. 2020; 15(1):77. PMC: 7147064. DOI: 10.1186/s13014-020-01513-7. View

Bird D, Henry A, Sebag-Montefiore D, Buckley D, Al-Qaisieh B, Speight R . A Systematic Review of the Clinical Implementation of Pelvic Magnetic Resonance Imaging-Only Planning for External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019; 105(3):479-492. DOI: 10.1016/j.ijrobp.2019.06.2530. View

Zakian K, Wibmer A, Vargas H, Alberts E, Kadbi M, Mychalczak B . Comparison of Motion-Insensitive T2-Weighted MRI Pulse Sequences for Visualization of the Prostatic Urethra During MR Simulation. Pract Radiat Oncol. 2019; 9(6):e534-e540. PMC: 6832802. DOI: 10.1016/j.prro.2019.06.009. View

Tenhunen M, Korhonen J, Kapanen M, Seppala T, Koivula L, Collan J . MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience. Acta Oncol. 2018; 57(7):902-907. DOI: 10.1080/0284186X.2018.1445284. View

Ranta I, Teuho J, Linden J, Klen R, Teras M, Kapanen M . Assessment of MRI-Based Attenuation Correction for MRI-Only Radiotherapy Treatment Planning of the Brain. Diagnostics (Basel). 2020; 10(5). PMC: 7278007. DOI: 10.3390/diagnostics10050299. View

Maspero M, van den Berg C, Landry G, Belka C, Parodi K, Seevinck P . Feasibility of MR-only proton dose calculations for prostate cancer radiotherapy using a commercial pseudo-CT generation method. Phys Med Biol. 2017; 62(24):9159-9176. DOI: 10.1088/1361-6560/aa9677. View

Roach 3rd M, Malfatti C, Holland J, Hricak H . Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1996; 35(5):1011-8. DOI: 10.1016/0360-3016(96)00232-5. View

Maspero M, Seevinck P, Schubert G, Hoesl M, van Asselen B, Viergever M . Quantification of confounding factors in MRI-based dose calculations as applied to prostate IMRT. Phys Med Biol. 2017; 62(3):948-965. DOI: 10.1088/1361-6560/aa4fe7. View

10.

Tyagi N, Fontenla S, Zelefsky M, Chong-Ton M, Ostergren K, Shah N . Clinical workflow for MR-only simulation and planning in prostate. Radiat Oncol. 2017; 12(1):119. PMC: 5513123. DOI: 10.1186/s13014-017-0854-4. View

11.

Kemppainen R, Suilamo S, Tuokkola T, Lindholm P, Deppe M, Keyrilainen J . Magnetic resonance-only simulation and dose calculation in external beam radiation therapy: a feasibility study for pelvic cancers. Acta Oncol. 2017; 56(6):792-798. DOI: 10.1080/0284186X.2017.1293290. View

12.

Tetar S, Bruynzeel A, Lagerwaard F, Slotman B, Bohoudi O, Palacios M . Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer. Phys Imaging Radiat Oncol. 2021; 9:69-76. PMC: 7807673. DOI: 10.1016/j.phro.2019.02.002. View

13.

Kim J, Glide-Hurst C, Doemer A, Wen N, Movsas B, Chetty I . Implementation of a novel algorithm for generating synthetic CT images from magnetic resonance imaging data sets for prostate cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2014; 91(1):39-47. DOI: 10.1016/j.ijrobp.2014.09.015. View

14.

Jonsson J, Nyholm T, Soderkvist K . The rationale for MR-only treatment planning for external radiotherapy. Clin Transl Radiat Oncol. 2019; 18:60-65. PMC: 6630106. DOI: 10.1016/j.ctro.2019.03.005. View

15.

Christiansen R, Jensen H, Brink C . Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancer. Acta Oncol. 2017; 56(6):787-791. DOI: 10.1080/0284186X.2017.1290275. View

16.

Olsson L, Johansson M, Zackrisson B, Blomqvist L . Basic concepts and applications of functional magnetic resonance imaging for radiotherapy of prostate cancer. Phys Imaging Radiat Oncol. 2021; 9:50-57. PMC: 7807726. DOI: 10.1016/j.phro.2019.02.001. View

17.

Grosu A, van der Heide U . Imaging for radiation treatment planning and monitoring in prostate Cancer: Precision, personalization, individualization of therapy. Phys Imaging Radiat Oncol. 2021; 11:61-62. PMC: 7807567. DOI: 10.1016/j.phro.2019.09.001. View

18.

den Hartogh M, de Boer H, de Groot-van Breugel E, van der Voort van Zyp J, Hes J, van der Heide U . Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator. Phys Imaging Radiat Oncol. 2021; 11:16-20. PMC: 7807729. DOI: 10.1016/j.phro.2019.07.002. View

19.

Kerkmeijer L, Maspero M, Meijer G, van der Voort van Zyp J, de Boer H, van den Berg C . Magnetic Resonance Imaging only Workflow for Radiotherapy Simulation and Planning in Prostate Cancer. Clin Oncol (R Coll Radiol). 2018; 30(11):692-701. DOI: 10.1016/j.clon.2018.08.009. View

20.

Kemppainen R, Suilamo S, Ranta I, Pesola M, Halkola A, Eufemio A . Assessment of dosimetric and positioning accuracy of a magnetic resonance imaging-only solution for external beam radiotherapy of pelvic anatomy. Phys Imaging Radiat Oncol. 2021; 11:1-8. PMC: 7807675. DOI: 10.1016/j.phro.2019.06.001. View